Ms. Sayali Kulkarni | Medicine and Dentistry | Editorial Board Member

Ms. Sayali Kulkarni | Medicine and Dentistry | Editorial Board Member

Georgian National University SEU | Georgia

Ms. Sayali Kulkarni is an emerging researcher with a strong foundation in medical sciences, recognized for her determination, disciplined work ethic, and commitment to continuous learning. She demonstrates a proactive approach to expanding her knowledge and shows significant potential for contributing to academic and clinical research. Her effective communication and interpersonal skills support collaborative work and the translation of research into patient-centered outcomes. As an early-career professional, she reflects the core values of research excellence and holds promise for meaningful contributions to the field.

View Orcid Profile

Featured Publications

Xiaofeng Shi | Medicine and Dentistry | Research Excellence Award

Xiaofeng Shi | Medicine and Dentistry | Research Excellence Award

The Second Affiliated Hospital of Nanjing Medical University | China

Dr. Xiaofeng Shi is a Chinese medical professional and researcher with a strong academic background in medicine and hematology. He earned his Bachelor’s degree from Jiangsu University, followed by a Master’s degree from the School of Medicine at Suzhou University. He later completed his doctoral studies in the Department of Hematology at Shanghai Jiao Tong University School of Medicine. His academic training reflects a focused expertise in medical sciences, particularly in the field of hematology, contributing to clinical research and healthcare advancement.

Citation Metrics (Scopus)

600450

300

150

0

Citations
563
Documents
51
h-index
10

VIEW SCOPUS PROFILE

Featured Publications


Endothelial Activation and Stress Index Serves as a Predictor for Survival in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

– American Journal of Hematology, 2025

Nomogram for predicting the 30- and 90-day prognoses of hemophagocytic lymphohistiocytosis patients: a multicenter and retrospective study

– Annals of Hematology, 2025

Evaluation of treatment for diffuse large B-cell lymphoma using plasma D-dimer levels

– Scientific Reports, 2025

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNS)

– Review, 2025

ITGA2B/ITGB3-Related Macrothrombocytopenia Associated With Gain-of-Function Mutations in ITGA2B or ITGB3 Genes

– Review, 2025

Fabio Sallustio | Medicine and Dentistry | Research Excellence Award

Fabio Sallustio | Medicine and Dentistry | Research Excellence Award

University of Bari Aldo Moro | Italy

Prof. Fabio Sallustio is an Associate Professor in Applied Medical Technical Science at the University of Bari “Aldo Moro,” where he conducts advanced research in renal biology and kidney diseases. His work primarily focuses on the genomic and functional characterization of adult renal stem/progenitor cells and their role in kidney repair, as well as the cellular and molecular mechanisms underlying kidney disorders, particularly IgA nephropathy. He has made significant contributions to understanding how renal progenitor cells activate reparative processes, including identifying key pathways such as Toll-like receptor 2–mediated signaling and their role in tissue regeneration, fibrosis prevention, and immunomodulation. In parallel, his research on IgA nephropathy has advanced knowledge of disease pathogenesis through the identification of dysregulated molecular pathways, epigenetic alterations, and genetic variations. He leads a multidisciplinary research team and actively supervises students and doctoral researchers in the fields of medical biotechnology and molecular medicine.

Citation Metrics (Scopus)

30002000

1000

500

0

Citations
2,697
Documents
96
h-index
32

VIEW SCOPUS PROFILE
VIEW Orcid PROFILE
VIEW Google Scholar PROFILE

Featured Publications

Bruno Mégarbane | Medicine and Dentistry | Research Excellence Award

Bruno Mégarbane | Medicine and Dentistry | Research Excellence Award

Université Paris Cité | France

Prof. Bruno Megarbane is a Professor at Université Paris Cité and serves as Head of the Department of Medical and Toxicological Critical Care at Lariboisière University Hospital. He is also a research team leader within the experimental research group at INSERM UMRS-1144. In addition, he acts as the medical head of the regional and national reference centre for chemicals, toxins, and toxicants (CORTOX), contributing to national health preparedness under the French General Direction of Health. His work primarily focuses on clinical toxicology, including drug poisoning, substance abuse, and envenomation.

Citation Metrics (Google Scholar)

40,00030,000

20,000

10,000

0

Citations

35,281

i10-index

402

h-index

90

View Google Scholar Profile
View Scopus Profile
View Orcid Profile
View PubMed Profile

Featured Publications


A communication strategy and brochure for relatives of patients dying in the ICU

– New England Journal of Medicine, 2007 (Cited by 1743)

High versus low blood-pressure target in patients with septic shock

– New England Journal of Medicine, 2014 (Cited by 1474)

Initiation strategies for renal-replacement therapy in the intensive care unit

– New England Journal of Medicine, 2016 (Cited by 1415)

Hydrocortisone plus fludrocortisone for adults with septic shock

– New England Journal of Medicine, 2018 (Cited by 1038)

Kapka Miteva | Health Professions | Excellence in Research Award

Kapka Miteva | Health Professions | Excellence in Research Award

University of Geneva, Faculty of Medicine | Switzerland

Dr. Kapka Miteva is a researcher in molecular medicine whose work spans regenerative therapies, cardiovascular repair, and high-dimensional analysis of inflammatory mechanisms in heart disease. She earned a master’s degree in Molecular Medicine from Charité University Medical School in Berlin, where she also began her scientific career at the BIH Center for Regenerative Therapies, focusing on regenerative and cardiovascular repair strategies. Her early research achievements culminated in a PhD awarded with summa cum laude, followed by a prestigious Career Development Grant through the Lydia Rabinowitsch Scholarship to support her postdoctoral studies at the same institute. Dr. Miteva’s findings have been disseminated through publications in leading peer-reviewed journals, including The European Heart Journal and Cardiovascular Research, underscoring her contribution to advancing translational cardiovascular science.

Citation Metrics (Scopus)

2000

1500

1000

500

0

Citations
1,834

Documents
45

h-index
22

                               Citations
         Documents
       h-index


View Scopus Profile

Featured Publications

Albina Tummolo | Medicine and Dentistry | Best Researcher Award

Albina Tummolo | Medicine and Dentistry | Best Researcher Award

Dr Albina Tummolo, Children Hospital Giovanni XXIII, Italy

Dr. Albina Tummolo, MD, PhD, MSc, is a highly experienced Consultant Pediatrician specializing in metabolic and genetic diseases. Based at the Department of Pediatrics, Ospedale Pediatrico “Giovanni XXIII” in Bari, Italy, she has been dedicated to advancing pediatric healthcare, particularly in the field of inherited metabolic disorders. With over two decades of clinical experience, Dr. Tummolo has played a leading role in national and international research studies focused on rare pediatric diseases. She is a principal investigator for multiple clinical trials and serves as a scientific advisor for global pharmaceutical and research initiatives. Her expertise spans lysosomal storage disorders, organic acidurias, PKU, and homocystinuria. Actively involved in advisory boards, working groups, and professional societies, she serves as the Scientific Secretary of SIMMESN. Dr. Tummolo is recognized for her leadership, compassionate care, and commitment to improving diagnostic and therapeutic strategies in pediatric metabolic medicine.

Publication Profile

orcid

Education

Dr. Albina Tummolo’s educational background is a testament to her dedication to pediatric medicine and rare disease research. She earned her MD in Medicine and Surgery from the University of Foggia in 2002, followed by a specialization in General and Specialist Pediatrics at the University of Bari in 2007. Her academic excellence continued with an MSc in Clinical Pediatrics from University College London (2008), and a PhD in Pediatric Sciences from the University of Bari (2011). She completed several post-graduate programs, including Pediatric Endocrinology, Infectivity and Pediatric Rheumatology, and Rare Diseases at the University of Florence. In 2023, she attained an MSc in Epidemiology and Biostatistics from Università Cattolica di Roma. She is also certified in Basic Life Support for Sanitary Operators by the Italian Resuscitation Council (2022). Her comprehensive education has built a strong foundation for her clinical, research, and academic leadership in pediatric metabolic diseases.

Experience

Dr. Tummolo has over 20 years of progressive experience in pediatric medicine, with a specialization in metabolic and genetic disorders. Since 2015, she has served as a Senior Pediatrician at Ospedale Pediatrico “Giovanni XXIII” in Bari. From 2014 to 2015, she contributed her expertise to the Unit of Inherited Metabolic Diseases at Azienda Ospedaliera di Padova. She previously held positions in the same department in Bari (2012–2014) and at Presidio Ospedaliero “Perrino” in Brindisi (2011). Her clinical leadership includes management of complex metabolic conditions, coordination of multidisciplinary teams, and engagement in translational research. She has also taken an active role in international collaborations, steering committees, and national consensus development initiatives. With her deep commitment to pediatric care, she has contributed to improving clinical protocols and advancing therapeutic options for children with rare diseases, while mentoring the next generation of pediatricians.

Awards and Honors

While specific award titles are not listed, Dr. Albina Tummolo’s continuous selection as Principal Investigator in high-impact multicenter studies and her active advisory roles reflect her esteemed reputation in pediatric metabolic medicine. She has served as an invited expert and advisor for numerous prestigious pharmaceutical boards including BioMarin, Alexion, Recordati, Ultragenyx, and Applied Pharma Research. Her involvement as a national scientific coordinator and member of European research networks, such as E-HOD and the Telethon Undiagnosed Diseases Program, underscores her leadership in rare disease research. She has also held positions of influence such as Scientific Secretary and Coordinator of International Cooperation within SIMMESN (Italian Scientific Society for Inborn Errors of Metabolism and Neonatal Screening). Through expert forums, national consensus meetings, and educational panels, she continues to shape policy, education, and clinical standards for rare pediatric disorders across Italy and Europe.

Research Focus

Dr. Tummolo’s research is deeply rooted in pediatric metabolic and genetic diseases. Her primary focus includes lysosomal storage disorders, amino acidopathies, organic acidurias, and disorders such as PKU, LAL-D, homocystinuria, and alpha-mannosidosis. She is particularly interested in the safety, efficacy, and long-term outcomes of enzyme replacement therapies and dietary management strategies. As a Principal Investigator, she has led numerous clinical trials, including studies on velmanase alfa, Orfadin, Carbaglu®, and Pegtibatinase. Her ongoing research evaluates patient-reported outcomes and real-world evidence in home infusion settings and drug therapies. She has also contributed to retrospective and prospective studies aimed at improving disease management, diagnosis, and therapeutic adherence. Additionally, her participation in the Simmesn Study Group on microbiota, metabolic diseases, and international cooperation reflects her commitment to translational and cooperative research. Dr. Tummolo’s work aims to enhance quality of life and clinical outcomes for children with rare metabolic conditions.

Publication Top Notes

  • 📘 An Observational Disease and Clinical Outcomes Registry of Patients with Lysosomal Acid Lipase (LAL) Deficiency – ALX-LALD

  • 🏠 HomERT: Safety of Myozyme and Aldurazyme in Real-world Home Infusion Settings

  • 👶 CCD-LMZYMAA1-08: Phase II Trial of Velmanase Alfa in Pediatric Alpha-Mannosidosis

  • 🧪 OPAL: Long Term Safety Study of Orfadin in Tyrosinemia Type 1

  • 💊 Understanding the Long-Term Management of Organic Acidemia Patients with Carbaglu®

  • 🌍 E-HOD: European Network and Registry for Homocystinurias and Methylation Defects

  • 🧬 TUDP: Telethon Undiagnosed Diseases Program Participation

  • 🧾 QOL-ONEPRO-G: Evaluating Patient-Reported Outcomes in Gaucher Disease (Planned 2025)

  • 🧑‍🔬 Harmony: Phase 3 Clinical Trial of Pegtibatinase in Classical Homocystinuria (Planned 2026)

  • 👧 Ensamble: Phase 3 Trial of Pegtibatinase in Pediatric Homocystinuria (Planned 2026)

  • 📊 CLARIFY-IT: Retrospective Study on PKU Disease Management in Italy (Planned 2025)

Dr Ayazullah Safi | Health Professions | Best Research Article Award

Dr Ayazullah Safi | Health Professions | Best Research Article Award

Dr Dr Ayazullah Safi, Birmingham City University, United Kingdom

Dr. Ayazullah Safi is a Senior Lecturer in the Department of Public Health at Birmingham City University, UK. With a dynamic career in teaching, research, and leadership, he specializes in health promotion, public health, physical activity, and nutrition. Dr. Safi has played pivotal roles in curriculum development, student supervision, and international research collaborations. He is also the founder of Anywhere Active, a platform that promotes physical wellbeing and community engagement. His academic journey is marked by innovative contributions across multiple education sectors, including higher education, secondary education, and community outreach. A committed mentor and educator, Dr. Safi is known for his ability to integrate theory with practical impact, particularly for underrepresented and vulnerable populations. His national and international recognition stems from his extensive research outputs, competitive grant success, and public health advocacy. Passionate about improving lives through education and evidence-based practices, Dr. Safi continues to inspire students, peers, and communities alike.

Publication Profile

orcid

Education

Dr. Safi earned his PhD in Public Health with a dissertation focused on workplace physical activity interventions and their impact on university employees’ health and wellbeing. He also holds a Master of Arts in Sport Studies and Physical Education, and a Bachelor of Arts in Sport Studies. In pursuit of teaching excellence, he obtained a Postgraduate Certificate in Research Practice in Higher Education, a Senior Fellowship from Advance HE, and completed an Academic Professional Apprenticeship. Additionally, he achieved the SEDA (Staff and Educational Development Association) Recognised Supervisor status, demonstrating his capability in mentoring and supervising academic research. Dr. Safi’s educational background reflects a strong commitment to advancing health sciences and pedagogy. His multi-disciplinary foundation empowers him to teach and lead across undergraduate, postgraduate, and foundation-level programmes with a rich understanding of both the scientific and sociocultural determinants of health, nutrition, and behaviour change.

Experience

Dr. Ayazullah Safi has accumulated over a decade of experience across public health, sports science, and education. He is currently a Senior Lecturer at Birmingham City University, where he serves as Deputy Course Leader for the MPH programme and leads multiple public health modules. Previously, he was a Lecturer and Course Leader for the MSc in Sport and Exercise Nutrition at the University of Westminster. His teaching spans undergraduate to postgraduate levels, with leadership in curriculum design, validation, and student supervision. He has also worked as a Consultant and Lecturer for the Workers’ Education Association, a Citizenship Teacher and Head of PE at Darul Uloom High School, and as the Director of community health initiatives such as Safi’s Sports and Fitness and Anywhere Active. His interdisciplinary experience in academia, community outreach, and project leadership reflects a well-rounded and impactful professional trajectory in promoting health and wellbeing through education and evidence-based practice.

Awards and Honors

Dr. Safi’s commitment to excellence in teaching, research, and community service has been widely recognised. In 2024/25, Birmingham City University was shortlisted for the prestigious Sir Lenny Henry Inclusivity Award under his leadership. He received Highly Commended distinctions for both Inspirational Teacher of the Year and Research Supervisor of the Year in 2023/24. In 2022, he was named a Role Model for Under-Represented Communities by the British Association of Sport and Exercise Sciences (BASES). His earlier accolades include the Contribution to the Community Award from the Youth Development Association in Afghanistan (2020), Research of the Year at Birmingham City University (2018/19), and Poster Presentation Prize Winner at the British Psychological Society (BPS) Annual Conference in 2019. These awards affirm Dr. Safi’s dedication to inclusive education, impactful research, and community wellbeing, marking him as an influential figure in both academic and grassroots health environments.

Research Focus

Dr. Ayazullah Safi’s research focuses on promoting health and wellbeing through physical activity, nutrition, and behaviour change strategies. His PhD examined the effects of workplace physical activity interventions on employee health and lifestyle transformation. He is particularly interested in interdisciplinary approaches that integrate public health, sports science, and leadership to address sedentary lifestyles, chronic disease prevention, and health inequalities. His work often targets underrepresented communities, promoting culturally sensitive, community-based health solutions. Dr. Safi has led and contributed to several funded research projects, including those on adolescent health in Saudi Arabia, healthy fan zones during Eurovision, and NHS health check focus groups. He is currently involved in multimorbidity prevention projects among BAME populations. By bridging academic theory and real-world application, his research supports both local and international public health initiatives, while fostering global academic collaborations and student-led investigations.

Publication Top Notes

  • 🧠 “Workplace Interventions and Wellbeing: A Meta-Analysis of University Staff Health” – Public Health Journal

  • 🏋️‍♂️ “Physical Activity Patterns Among UK Office Workers Post-COVID-19” – Journal of Exercise Science

  • 🍎 “Precision Nutrition in Community Health Programmes” – Global Nutrition Insights

  • 🌍 “Decolonising Health Curricula: Challenges and Strategies” – Education and Society

  • 💬 “Community Voices: Evaluating NHS Health Checks through Focus Groups” – Health Policy and Planning

Michael Keese | Medicine | Best Review Article Award

Assoc. Prof. Dr. Michael Keese | Medicine | Best Review Article Award 

Assoc. Prof. Dr. Michael Keese, TKH Mannheim, Germany

Assoc. Prof. Dr. Michael Keese is a distinguished researcher and educator at TKH Mannheim, Germany. He earned his doctorate (summa cum laude) in 1998 from the Biochemical Institute 2 at the University of Heidelberg. Following a decade of research and teaching at the University Medical Center Mannheim (UMM), he completed his habilitation. In 2013, he re-habilitated at the Medical Faculty of Goethe University Frankfurt and was appointed as an extraordinary professor in 2015. He rejoined UMM Mannheim in 2017 while continuing his teaching at the University Hospital Frankfurt. In 2023, he was appointed as a Visiting Professor at Baku State University, Azerbaijan.

Education:

Doctorate (PhD): Biochemical Institute 2, University of Heidelberg, Germany (1998) – Summa cum laude

Habilitation: University Medical Center Mannheim (UMM), Germany (after 10 years of research and teaching)

Re-habilitation: Medical Faculty, Goethe University Frankfurt, Germany (2013)

Professional Profiles:

ORCID Profile

Professional Experience:

Director, Department of Vascular and Endovascular Surgery, Theresienkrankenhaus and Diako Mannheim (since April 2022)

Visiting Professor, Baku State University, Azerbaijan (since November 2023)

Editor, Journal of Clinical Medicine (JCM) (since February 2023)

Head of Vascular Surgery, Universitätsmedizin Mannheim (2017–2022)

Head of Transplant Surgery, Universitätsmedizin Mannheim (2018–2022)

Deputy Clinic Director & Chief Senior Physician, Department of Vascular and Endovascular Surgery, Johann Wolfgang Goethe University Frankfurt (2015–2017)

Senior Physician & Head of Endovascular Surgery, Department of Vascular and Endovascular Surgery, Johann Wolfgang Goethe University Frankfurt (2011–2015)

Deputy Head, Vascular Surgery Section, Universitätsmedizin Mannheim (2010–2011)

Senior Physician, Department of Surgery, Universitätsmedizin Mannheim (2010–2011)

Specialist in Vascular Surgery, Universitätsmedizin Mannheim (2010)

Assistant Physician & Specialist in Surgery, Universitätsmedizin Mannheim (2004–2010)

Assistant Physician, Department of Surgery, Universitätsmedizin Mannheim (1999–2003)

Postdoctoral Researcher, EMBL Heidelberg (2003–2004)

Research Interests:

Establishment of novel imaging models for monitoring receptor tyrosine kinases

Contributions to the cell biology of mesenchymal stem cells, particularly their influence on vascular muscle cells and human umbilical vein endothelial cells (HUVECs)

siRNA and microRNA profiling of vascular smooth muscle cells (VSMCs) and endothelial cells

Top Notable Publications:

The Differentiation and Regeneration Potential of ABCB5+ Mesenchymal Stem Cells: A Review and Clinical Perspectives

Journal: Journal of Clinical Medicine

Date: 2025-01-21

DOI: 10.3390/jcm14030660

Contributors: Zheng He, Vytaute Starkuviene, Michael Keese

2. MTHFR Gene C677T Polymorphism (rs1801133) and Susceptibility to Colorectal Polyps in an Azerbaijani Population

Journal: Journal of Clinical Medicine

Date: 2023-12-30

DOI: 10.3390/jcm13010219

Contributors: Hazi Aslanov, Bayram Bayramov, Christoph Reissfelder, Shams Abdullayeva, Zeynab Mammadova, Fikrat Aliyev, Michael Keese, Javahir Hajibabazade, Vugar Yagublu

3. Adipose-Derived Mesenchymal Stem Cells Protect Endothelial Cells from Hypoxic Injury by Suppressing Terminal UPR In Vivo and In Vitro

Journal: International Journal of Molecular Sciences

Date: 2023-12-06

DOI: 10.3390/ijms242417197

Contributors: Michael Keese, Jiaxing Zheng, Kaixuan Yan, Karen Bieback, Benito A. Yard, Prama Pallavi, Christoph Reissfelder, Mark Andreas Kluth, Martin Sigl, Vugar Yagublu

4. A Systematic Review and Bayesian Network Meta-Analysis on the Effect of Different Anticoagulants on the Prophylaxis of Post-Thrombotic Syndrome after Deep Venous Thrombosis

Journal: Journal of Clinical Medicine

Date: 2023-11-30

DOI: 10.3390/jcm12237450

Contributors: Jingbo Shao, Qianwen Zhou, Fukang Jin, Christoph Reissfelder, Martin Sigl, Vugar Yagublu, Michael Keese

5. Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines

Journal: International Journal of Molecular Sciences

Date: 2023-08

DOI: 10.3390/ijms241713530

Contributors: Feng Guo, Kejia Kan, Felix Rückert, Wolfgang Rückert, Lin Li, Johannes Eberhard, Tobias May, Carsten Sticht, Wilhelm Gerhard Dirks, Christoph Reissfelder et al.

6. Analysis of Inflammation-Related Genes in Patients with Stanford Type A Aortic Dissection

Journal: Journal of Personalized Medicine

Date: 2023-06-13

DOI: 10.3390/jpm13060990

Contributors: Lin Li, Ziwei Zeng, Vugar Yagublu, Nuh Rahbari, Christoph Reißfelder, Michael Keese

7. Investigation of Different Methods of Intraoperative Graft Perfusion Assessment during Kidney Transplantation for the Prediction of Delayed Graft Function: A Prospective Pilot Trial

Journal: Journal of Personalized Medicine

Date: 2022-10

DOI: 10.3390/jpm12101749

Contributors: Andreas Gerken, Michael Keese, Christel Weiss, Hanna-Sophie Krücken, Katarina A. P. Pecher, Augusto Ministro, Nuh N. Rahbari, Christoph Reissfelder, Ulrich Rother, Babak Yazdani et al.

Conclusion:

Assoc. Prof. Dr. Michael Keese is a strong contender for the “Best Review Article Award.” His significant contributions to advancing stem cell research, particularly in the differentiation and regenerative potential of ABCB5+ mesenchymal stem cells, align well with the objectives of this award. His work is not only well-regarded in academic circles but also demonstrates the potential to improve clinical applications, making it highly relevant to current scientific and medical challenges.

 

Giulia Passaniti | Medicine | Best Review Article Award

Dr. Giulia Passaniti | Medicine | Best Review Article Award

Dr. Giulia Passaniti, Centro Alte Specialità e Trapianti- Policlinico G. Rodolico- San Marco, Italy

Dr. Giulia Passaniti is a highly accomplished medical professional specializing in cardiovascular imaging and structural heart interventions. She is currently pursuing an Imaging Fellowship for Structural Heart Interventions at Mount Sinai Hospital, New York (2023-2024). Dr. Passaniti has also completed advanced training in Stress, Transesophageal, and Advanced Echocardiography at the Azienda Ospedaliera Università di Padova, where she earned a Second-Level Master’s Degree with Summa Cum Laude (2022-2023).

Education:

Imaging Fellowship for Structural Heart Interventions

Institution: Mount Sinai Hospital, New York

Duration: 07/01/2023 – 06/30/2024

Stress, Transesophageal, and Advanced Echocardiography

Institution: Azienda Ospedaliera Università di Padova – Cardiovascular Disease Department

Degree: Second-Level Master’s Degree

Duration: 11/01/2022 – 09/22/2023

Honors: Graduated Summa cum laude

Cardiovascular Diseases Fellowship

Institution: Azienda Ospedaliera Universitaria Policlinico “G. Rodolico”, Catania, Italy

Duration: 01/26/2021 – 01/26/2025

Clinical Clerkship

Institution: Policlinico “G. Rodolico”, Catania, Italy

Duration: 10/01/2018 – 01/31/2019

Medical Education (Doctor of Medicine – MD)

Institution: Facoltà di Medicina e Chirurgia, Università di Catania

Duration: 10/06/2012 – 07/18/2018

Honors: Graduated Summa cum laude on 07/18/2018

Professional Profiles:

ORCID Profile

Google Scholar

Professional Experience:

Dr. Giulia Passaniti has gained extensive medical experience through various roles in Italy’s healthcare system. From February 2020 to December 2020, she served as a Medical Doctor at Centro Alte Specialità e Trapianti- Policlinico G. Rodolico- San Marco, where she contributed to specialized medical care and transplant-related services. Prior to this, from November 2019 to February 2020, she worked at Centro Multispecialistico Etneo, gaining experience in a multidisciplinary clinical setting. Additionally, she provided medical care at Guardia Medica of Aci Sant’Antonio from November 2019 to February 2020 and at Guardia Medica of Pedara from July 2019 to September 2019, where she was responsible for emergency medical assistance and primary healthcare services. Her diverse clinical background highlights her ability to adapt to different medical environments and provide high-quality patient care.

Top Notable Publications:

Role of advanced cardiovascular imaging in chemotherapy-induced cardiotoxicity
Heliyon, 2023
Contributors: MT Cannizzaro, MC Inserra, G Passaniti, A Celona, T D’Angelo, P Romeo, et al.

Pulmonary hypertension
Novel Pathogenesis and Treatments for Cardiovascular Disease, 2022
Contributors: M Mulè, G Passaniti, D Giannazzo

MR imaging of primary benign cardiac tumors in the pediatric population
Heliyon, 2023
Contributors: MC Inserra, MT Cannizzaro, G Passaniti, A Celona, A Secinaro, et al.

Transcatheter Edge-to-Edge Approach to Repair Large Coaptation Gaps: The Zipping Technique
Cardiovascular Interventions, 2024
Contributors: G Passaniti, GHL Tang, R Tanner, SK Sharma, AS Kini, S Lerakis

Do we still need intra-procedural TTE during Transcatheter aortic valve replacement? A high volume, single center experience
Cardiovascular Revascularization Medicine, 2024
Contributors: YN Granot, G Passaniti, FR Prandi, SK Sharma, A Kini, S Lerakis

Echo HALT: do we really need a cardiac CT?
The International Journal of Cardiovascular Imaging, 2024
Contributors: G Passaniti, FR Prandi, S Sharma, A Kini, S Lerakis

Fundamental Roles of Intracardiac Echocardiography and Fluoroscopy in Redo Tricuspid Transcatheter Edge-to-Edge Repair Procedure
Cardiovascular Interventions, 2024
Contributors: G Passaniti, LM Safi, F Prandi, S Ratanapo, S Lerakis, GHL Tang, et al.

IMPACT OF AORTIC VALVE CALCIFICATION SEVERITY IN PATIENTS WITH LOW-FLOW LOW-GRADIENT AORTIC STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
Journal of the American College of Cardiology, 2024
Contributors: R Singh, L Chopra, D Sperling, A Dalsania, H Ueyama, FR Prandi, et al.

Imaging in a Rare Case of Neonatal Arterial Tortuosity Syndrome
Global Medical Genetics, 2023
Contributors: MC Inserra, A Di Mari, G Passaniti, MT Cannizzaro, G La Rosa, D Poli, et al.

Myocardial fibrosis in aortic stenosis: Comparison between clinical data, laboratory, echocardiography, and cardiac magnetic resonance
Journal of Cardiology and Cardiovascular Medicine, 2023
Contributors: G Tosto, G Passaniti, FA Gibiino, W Deste, A Indelicato, T Torrisi, et al.

Conclusion:

Dr. Giulia Passaniti is a highly suitable candidate for the Research for Best Review Article Award due to her expertise in cardiovascular imaging, extensive collaborations, and high-quality publications. Strengthening her focus on systematic reviews and increasing outreach efforts could further solidify her eligibility for this prestigious recognition.